Peek behind the paper: evaluating the economic burden and health outcomes of hospitalized individuals with COVID-19 in the USA

Written by MANUELA DI FUSCO (PFIZER INC.)

In this feature, we take a ‘peek behind the paper’ with Manuela Di Fusco (Pfizer Inc., NY, USA), a member of our Expert Panel on The Evidence Base®, to discuss recent research she was involved in evaluating the economic burden and health outcomes of hospitalized individuals with COVID-19 in the USA recorded in the Premier Healthcare COVID-19 Database. Read the full research paper here >>> Please could you introduce yourself and give a short summary of your research career to date? I am a Director in the Patient and Health Impact team at Pfizer Inc. My academic background is in...

To view this content, please register now for access

It's completely free